Am J Obstet Gynecol

1. DENGLER KL, Craig ER, Dicarlo-Meacham AM, Welch EK, et al
   Preoperative pudendal block with liposomal and plain bupivacaine reduces pain associated with posterior colporrhaphy: a double-blinded, randomized controlled trial.
   Am J Obstet Gynecol. 2021 Aug 30. pii: S0002-9378(21)00968.
   

   >> Share

   
   
2. HIRSHBERG JS, Cooke E, Oakes MC, Odibo AO, et al
   Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: Initial report.
   Am J Obstet Gynecol. 2021 Aug 25. pii: S0002-9378(21)00952.
   

   >> Share

   
   
3. LAI J, Romero R, Tarca AL, Iliodromiti S, et al
   SARS-COV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose response relationship supporting causality.
   Am J Obstet Gynecol. 2021 Aug 26. pii: S0002-9378(21)00947.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

4. PEPIN JL, Daabek N, Bailly S, Tamisier R, et al
   Poor Adherence to Continuous Positive Airway Pressure Hugely Improved During COVID-19 Lockdown in France.
   Am J Respir Crit Care Med. 2021 Sep 1. doi: 10.1164/rccm.202103-0803.
   

   >> Share

   
   

   
   Ann Intern Med

5. DEEPAK P, Kim W, Paley MA, Yang M, et al
   Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-1757.
   

   >> Share

   
   
6. LI O
   Annals Graphic Medicine - Wanted: All COVID-19 Variants.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/G21-0048.
   

   >> Share

   
   
7. PALTIEL AD, Schwartz JL
   Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
   

   >> Share

   
   
8. AUWAERTER PG
   The Race to Understand Post-COVID-19 Conditions.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-3072.
   

   >> Share

   
   

   
   BMJ

9. BINGHAM R, Pickles H
   Prolonged solitary confinement of UK immigration detainees during the pandemic.
   BMJ. 2021;374:n2016.
   

   >> Share

   
   
10. MCCARTNEY M, Byng R
    Long covid clinics should be run as research hubs.
    BMJ. 2021;374:n1996.
    

    >> Share

    
    
11. WILKINSON E
    How routine NHS diabetes care can catch up after covid-19.
    BMJ. 2021;374:n1927.
    

    >> Share

    
    
12. BARANIUK C
    Covid-19: Why is Northern Ireland's death rate so high?
    BMJ. 2021;374:n2129.
    

    >> Share

    
    
13. WISE J
    Covid-19: Delta variant doubles risk of hospital admission compared with alpha variant, study shows.
    BMJ. 2021;374:n2152.
    

    >> Share

    
    
14. FENTON L, Gribben C, Caldwell D, Colville S, et al
    Risk of hospital admission with covid-19 among teachers compared with healthcare workers and other adults of working age in Scotland, March 2020 to July 2021: population based case-control study.
    BMJ. 2021;374:n2060.
    

    >> Share

    
    
15. WISE J
    Covid-19: 80% of young adults in UK are likely to have antibodies, data suggest.
    BMJ. 2021;374:n2162.
    

    >> Share

    
    
16. FALLOWS ESV
    Covid-19 and GPs: the unmeasured goes unnoticed.
    BMJ. 2021;374:n2140.
    

    >> Share

    
    
17. WISE J
    Covid-19: UK will offer third vaccine dose to severely immunosuppressed people.
    BMJ. 2021;374:n2160.
    

    >> Share

    
    
18. SIDEBOTTOM DB, Gill D
    Ronapreve for prophylaxis and treatment of covid-19.
    BMJ. 2021;374:n2136.
    

    >> Share

    
    
19. BHARGAVA A
    Broader approaches are necessary for containing pandemics like covid-19.
    BMJ. 2021;374:n2107.
    

    >> Share

    
    

    
    Clin Chem

20. ZHANG YV, Wiencek J, Meng QH, Theel ES, et al
    AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories.
    Clin Chem. 2021;67:1188-1200.
    

    >> Share

    
    

    
    Clin Infect Dis

21. MACK CD, Tai C, Sikka R, Grad YH, et al
    SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort.
    Clin Infect Dis. 2021 Aug 28. pii: 6359055. doi: 10.1093.
    

    >> Share

    
    
22. WYNBERG E, van Willigen HDG, Dijkstra M, Boyd A, et al
    Evolution of COVID-19 symptoms during the first 12 months after illness onset.
    Clin Infect Dis. 2021 Sep 2. pii: 6362727. doi: 10.1093.
    

    >> Share

    
    
23. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    

    >> Share

    
    
24. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    

    >> Share

    
    
25. TAGLIAMONTE MS, Mavian C, Zainabadi K, Cash MN, et al
    Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti.
    Clin Infect Dis. 2021 Sep 2. pii: 6359631. doi: 10.1093.
    

    >> Share

    
    
26. STRICH JR, Tian X, Samour M, King CS, et al
    Fostamatinib for the treatment of hospitalized adults with COVD-19 A randomized trial.
    Clin Infect Dis. 2021 Sep 1. pii: 6358811. doi: 10.1093.
    

    >> Share

    
    
27. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    

    >> Share

    
    
28. MARTINEZ DA, Klein EY, Parent C, Prieto D, et al
    Latino Household Transmission of SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 31. pii: 6360016. doi: 10.1093.
    

    >> Share

    
    
29. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    

    >> Share

    
    
30. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    

    >> Share

    
    
31. GOTTLIEB L, Fridkin SK
    It's hard to measure success while caring for surges in COVID-19 hospitalizations.
    Clin Infect Dis. 2021 Aug 28. pii: 6359066. doi: 10.1093.
    

    >> Share

    
    
32. XIN H, Li Y, Wu P, Li Z, et al
    Estimating the latent period of coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2021 Aug 28. pii: 6359063. doi: 10.1093.
    

    >> Share

    
    

    
    Emerg Infect Dis

33. CHOI GJ, Baek SH, Kim J, Kim JH, et al
    Fatal Systemic Capillary Leak Syndrome after SARS-COV-2Vaccination in Patient with Multiple Myeloma.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
34. SANDER AL, Yadouleton A, de Oliveira Filho EF, Tchibozo C, et al
    Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early 2021.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
35. BROOKS YM, Gryskwicz B, Sheehan S, Piers S, et al
    Detection of SARS-CoV-2 in Wastewater at Residential College, Maine, USA, August-November 2020.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
36. SAMORE MH, Looney A, Orleans B, Greene T, et al
    Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
37. CHUNG GKK, Chan SM, Chan YH, Woo J, et al
    Socioeconomic Patterns of COVID-19 Clusters in Low-Incidence City, Hong Kong.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
38. SURASI K, Cummings KJ, Hanson C, Morris MK, et al
    Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
39. ALLAM C, Gaymard A, Descours G, Ginevra C, et al
    Co-infection with Legionella and SARS-CoV-2, France, March 2020.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
40. KLEYNHANS J, Tempia S, Wolter N, von Gottberg A, et al
    SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    

    
    Infect Control Hosp Epidemiol

41. OZARAS R, Dilek A, Sunbul M, Leblebicioglu H, et al
    Association between Crimean-Congo hemorrhagic fever (CCHF) and coronavirus disease 2019 (COVID-19): A systematic review.
    Infect Control Hosp Epidemiol. 2021 Aug 31:1-5. doi: 10.1017/ice.2021.
    

    >> Share

    
    
42. WINK PL, Volpato FCZ, Monteiro FL, Willig JB, et al
    First identification of SARS-CoV-2 Lambda (C.37) variant in Southern Brazil.
    Infect Control Hosp Epidemiol. 2021 Sep 2:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
43. WEINER-LASTINGER LM, Pattabiraman V, Konnor RY, Patel PR, et al
    The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network.
    Infect Control Hosp Epidemiol. 2021 Sep 3:1-14. doi: 10.1017/ice.2021.
    

    >> Share

    
    

    
    Int J Infect Dis

44. DE GUADIANA-ROMUALDO LG, Martinez MM, Mulero MDR, Torrella PE, et al
    Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
    Int J Infect Dis. 2021 Aug 27. pii: S1201-9712(21)00692.
    

    >> Share

    
    
45. SALVAGNO GL, Henry BM, Lippi G
    The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00693.
    

    >> Share

    
    
46. DIRKX KKT, Mulder B, Post AS, Rutten MH, et al
    The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00691.
    

    >> Share

    
    
47. POUR OB, Yahyavi Y, Karimi A, Khamaneh AM, et al
    Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00686.
    

    >> Share

    
    
48. CHEN Y, Yao H, Fu J, Shu Q, et al
    The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00672.
    

    >> Share

    
    

    
    Intensive Care Med

49. VELU PP, Lucas CD, Conway Morris A
    Post-mortem dissection of COVID-19: a pathogenic role for macrophages?
    Intensive Care Med. 2021 Sep 1. pii: 10.1007/s00134-021-06509.
    

    >> Share

    
    
50. PRATTES J, Koehler P, Hoenigl M
    COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges.
    Intensive Care Med. 2021 Sep 1. pii: 10.1007/s00134-021-06510.
    

    >> Share

    
    

    
    J Infect

51. QIU S, Hu Y, Cheng L
    A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
    J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
    

    >> Share

    
    
52. SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
    SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
    

    >> Share

    
    
53. STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
    Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
    

    >> Share

    
    
54. BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
    Healthcare-associated COVID-19 in England: a national data linkage study.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
    

    >> Share

    
    

    
    J Med Virol

55. FINSTERER J, Almas T
    Guillain-Barre syndrome is immunogenic in SARS-CoV-2 infected.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27314.
    

    >> Share

    
    
56. SODEIFIAN F, Nikfarjam M, Kian N, Mohamed K, et al
    The Role of Type I Interferon in the Treatment of COVID-19.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27317.
    

    >> Share

    
    
57. PANDA S, Roy S, Garg RK, Hui G, et al
    COVID-19 Disease in Hospitalised Young Adults in India and China: Evaluation of Risk Factors Predicting Progression Across Two Major Ethnic Groups.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27315.
    

    >> Share

    
    
58. YALCIN TY, Topcu DI, Dogan O, Aydin S, et al
    Immunogenicity After Two Doses of Inactivated Virus Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: Prospective Observational Study.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27316.
    

    >> Share

    
    
59. MALIK P, Patel K, Pinto C, Jaiswal R, et al
    Post-acute COVID-19 syndrome (PCS) and Health related Quality of life (HRQoL)- A systematic review and Meta-analysis.
    J Med Virol. 2021 Aug 31. doi: 10.1002/jmv.27309.
    

    >> Share

    
    
60. MOUSAVI SA, Heydari K, Mehravaran H, Saeedi M, et al
    Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, Randomized, Controlled Trial.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27312.
    

    >> Share

    
    
61. AKINOSOGLOU K, Delastic AL, Dimakopoulou V, Marangos M, et al
    Elements of Th1 / Th2 response and disease severity in COVID-19 patients: A short report.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27313.
    

    >> Share

    
    
62. FERNANDEZ J, Bruneau N, Fasce R, Martin HS, et al
    Neutralization of Alpha, Gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27310.
    

    >> Share

    
    
63. WASIM U, Tahir MJ, Siddiqi AR, Jabbar A, et al
    The impact of the COVID-19 pandemic on impending cancer deaths due to delays in diagnosis in the UK.
    J Med Virol. 2021 Aug 28. doi: 10.1002/jmv.27305.
    

    >> Share

    
    
64. MISHRA B, Ranjan J, Purushotham P, Saha S, et al
    High proportion of low cycle threshold value as an early indicator of COVID-19 surge.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27307.
    

    >> Share

    
    
65. XIE XP, Sheng LP, Han CQ, Jin Y, et al
    Features of capsule endoscopy in COVID-19 patients with a six-month follow up: a prospective observational study.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27308.
    

    >> Share

    
    

    
    J Travel Med

66. RIVA MA, Paladino ME, Brambilla S, Belingheri M, et al
    COVID-19 health passes. Lessons from the past.
    J Travel Med. 2021 Sep 2. pii: 6362847. doi: 10.1093.
    

    >> Share

    
    

    
    JAMA

67. UYOGA S, Adetifa IMO, Otiende M, Yegon C, et al
    Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
    JAMA. 2021 Sep 2. pii: 2784014. doi: 10.1001/jama.2021.15265.
    

    >> Share

    
    
68. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    

    >> Share

    
    
69. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    

    >> Share

    
    
70. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    

    >> Share

    
    
71. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    

    >> Share

    
    

    
    Lancet

72. THORNTON J
    Focusing on island health.
    Lancet. 2021;398:569-570.
    

    >> Share

    
    
73. DANIELS JP
    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    

    >> Share

    
    
74. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    

    >> Share

    
    
75. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    

    >> Share

    
    
76. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    

    >> Share

    
    
77. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    

    >> Share

    
    

    
    Lancet Infect Dis

78. TWOHIG KA, Nyberg T, Zaidi A, Thelwall S, et al
    Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
    Lancet Infect Dis. 2021 Aug 27. pii: S1473-3099(21)00475.
    

    >> Share

    
    
79. LECHIEN JR, Saussez S
    Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants.
    Lancet Infect Dis. 2021 Aug 27. pii: S1473-3099(21)00474.
    

    >> Share

    
    

    
    Life Sci

80. PAL D, Goyal J, Sharma U, Sharma A, et al
    Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope.
    Life Sci. 2021;284:119901.
    

    >> Share

    
    
81. LUTHRA R, Kaur S, Bhandari K
    Applications of CRISPR as a potential therapeutic.
    Life Sci. 2021 Aug 25:119908. doi: 10.1016/j.lfs.2021.119908.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

82. LAM-HINE T, McCurdy SA, Santora L, Duncan L, et al
    Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1214-1219.
    

    >> Share

    
    
83. DOYLE K, Teran RA, Reefhuis J, Kerins JL, et al
    Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1195-1200.
    

    >> Share

    
    
84. NERHOOD KJ, James ER, Hardin A, Bray JE, et al
    Screening Programs for SARS-CoV-2 Infections on a University Campus - Austin, Texas, September 30-November 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1201-1205.
    

    >> Share

    
    
85. BOEHMER TK, Kompaniyets L, Lavery AM, Hsu J, et al
    Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1228-1232.
    

    >> Share

    
    
86. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1183-1190.
    

    >> Share

    
    
87. MATTHIAS J, Patrick S, Wiringa A, Pullman A, et al
    Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men's Conference - Illinois, June-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1223-1227.
    

    >> Share

    
    
88. MURTHY BP, Zell E, Saelee R, Murthy N, et al
    COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1206-1213.
    

    >> Share

    
    
89. YIN S, Barnes K, Fisher R, Terashita D, et al
    COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community - Los Angeles County, California, September 2020-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1220-1222.
    

    >> Share

    
    

    
    N Engl J Med

90. MELLO MM, Parmet WE
    Public Health Law after Covid-19.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMp2112193.
    

    >> Share

    
    
91. KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
    Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
    

    >> Share

    
    
92. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    

    >> Share

    
    
93. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Round of Rising Covid-19 Numbers.
    N Engl J Med. 2021;385:e41.
    

    >> Share

    
    

    
    Nature

94. 
    COVID in Venezuela, health trials suppressed - the week in infographics.
    Nature. 2021 Aug 27. pii: 10.1038/d41586-021-02364.
    

    >> Share

    
    
95. LEMPP FA, Soriaga L, Montiel-Ruiz M, Benigni F, et al
    Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
    Nature. 2021 Aug 31. pii: 10.1038/s41586-021-03925.
    

    >> Share

    
    
96. MAXMEN A
    US COVID origins report: researchers pleased with scientific approach.
    Nature. 2021 Aug 27. pii: 10.1038/d41586-021-02366.
    

    >> Share

    
    
97. KWON D
    Rogue antibodies involved in almost one-fifth of COVID deaths.
    Nature. 2021 Aug 31. pii: 10.1038/d41586-021-02337.
    

    >> Share

    
    

    
    Radiology

98. GARG M, Prabhakar N, Muthu V, Farookh S, et al
    CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.
    Radiology. 2021 Aug 31:211583. doi: 10.1148/radiol.2021211583.
    

    >> Share

    
    

    
    Science

99. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    

    >> Share

    
    

    
    Travel Med Infect Dis

100. DILEK A, Ozaras R, Ozkaya S, Sunbul M, et al
     COVID-19-associated mucormycosis: Case report and systematic review.
     Travel Med Infect Dis. 2021;44:102148.
     

     >> Share

     
     
101. RODRIGUEZ-MORALES AJ, Mamani-Garcia CS, Nunez-Lupaca JN, Leon-Figueroa DA, et al
     COVID-19 and mucormycosis in Latin America - An emerging concern.
     Travel Med Infect Dis. 2021;44:102156.
     

     >> Share

     
     
102. CONCEICAO GMS, Barbosa GL, Lorenz C, Bocewicz ACD, et al
     Effect of social isolation in dengue cases in the state of Sao Paulo, Brazil: An analysis during the COVID-19 pandemic.
     Travel Med Infect Dis. 2021;44:102149.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share